Tag Archives: sbir

Cohen, Boyer & Tibbetts?

SBIR Reauthorization Moves Forward

Ask any biotech professional about Stanley Cohen and Herbert Boyer and they will tell you about their incredible contributions to modern biotechnology. But what about Roland Tibbetts? My guess is there are more than a few quizzical looks out there. So who is Roland Tibbetts? In many ways, Roland Tibbetts did for the commercialization of biotechnology, what Cohen and Boyer did for the science. He is the creator of the Small Business Innovation Research (SBIR) Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

BIO Investor Forum to Showcase NSF-funded Companies

150639480

No risk, no reward—that’s the concept driving the startups and entrepreneurs scheduled to present at next week’s 12th Annual BIO Investor Forum as a part of the newly-announced National Science Foundation (NSF) track of presenting companies. Expanding on the success of the Discovery Track Presentations, the 2013 BIO Investor Forum will feature a dedicated track of 10 NSF-funded companies focused on drug discovery, diagnostics and other related technologies. The companies are supported by the NSF Small Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

SBIR Reauthorization Moves Forward

SBIR Reauthorization Moves Forward

NIH has reissued its Small Business Innovation Research (SBIR) Omnibus Grant Solicitation announcement, which states that small businesses that are majority-owned by multiple venture capital operating companies are eligible to apply for (1) these SBIR grants and (2) any other NIH SBIR funding opportunities announced after January 28, 2013.  The NIH grant solicitation announcement can be found here. With this re-issuance, small businesses that are majority-owned by multiple venture capital operating companies (VCOCs), hedge funds Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , ,

We Are BIO

Jim Greenwood

Here’s what the Biotechnology Industry Organization is doing for you. This year, we challenged you to answer the question – What’s Your BIO? On behalf of the Biotechnology Industry Organization (BIO), I’d like to answer that question to illustrate how we advocate for federal, state and global policies to foster continued biotech breakthroughs, innovation and ingenuity. In addition to producing the BIO International Convention, we educate and engage public policy leaders in Washington, in state Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , ,

BIO Supports SBIR Reauthorization in Senate

Capitol

Last week, the Senate passed the National Defense Authorization Act (S. 1867), which included SBIR reauthorization through Senate Amendment 1115. This is a critical step toward ensuring that all innovative companies can compete for SBIR grants – based on the promise of their science rather than the structure of their capital.  Reauthorizing the program to allow small companies that receive the majority of their financing from venture capital to once again be eligible to compete Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , , ,